Pembrolizumab Plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer: A Randomized, Doubleblind, Phase III ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study

No Thumbnail Available

Files

PIIS0923753423041765.pdf (88.03 KB)

Date

2023

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

http://hdl.handle.net/11727/12120
 https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2823%2904176-5

Collections

Tıp Fakültesi / Faculty of Medicine

Endorsement

Review

Supplemented By

Referenced By